Use of topical FK506 in a corneal graft rejection model in Lewis rats

Investigative Ophthalmology and Visual Science

Volumn 38, Issue 5, 1997, Pages 901-909

  Hikita, Naofumi ^a   Lapez, Juan S ^b   Chan, Chi Chao ^b   Mochizuki, Manabu ^a   Nussenblatt, Robert B ^b   De Smet, Marc D ^b  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NATIONAL EYE INSTITUTE   (United States)

Author keywords

FK506; graft rejection; immunohistochemistry; penetrating keratoplasty; topical treatment

Indexed keywords

TACROLIMUS;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; CORNEA TRANSPLANTATION; DRUG EFFICACY; GRAFT REJECTION; HELPER CELL; IMMUNOSUPPRESSIVE TREATMENT; INTRAPERITONEAL DRUG ADMINISTRATION; LYMPHOCYTIC INFILTRATION; NONHUMAN; PRIORITY JOURNAL; RAT; T LYMPHOCYTE ACTIVATION;

ADMINISTRATION, TOPICAL; ANIMALS; CORNEA; DISEASE MODELS, ANIMAL; FEMALE; GRAFT REJECTION; HISTOCOMPATIBILITY ANTIGENS CLASS II; IMMUNOSUPPRESSIVE AGENTS; KERATOPLASTY, PENETRATING; MACROPHAGES; OPHTHALMIC SOLUTIONS; RATS; RATS, INBRED F344; RATS, INBRED LEW; RECEPTORS, INTERLEUKIN-2; T-LYMPHOCYTES, CYTOTOXIC; T-LYMPHOCYTES, HELPER-INDUCER; TACROLIMUS; TRANSPLANTATION, HOMOLOGOUS;

EID: 0030934367     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Lindstrom RL. Advances in corneal transplantation. N Engl J Med. 1986;315:1-9.
2. Stern GA. Update on the medical management of cornea and external eye diseases, corneal transplantation and keratorefractive surgery. Ophthalmology. 1988;95:842-854.
3. Hoffmann F, Wiederholt M. Topical cyclosporin A in the treatment of corneal graft rejection. Cornea. 1986;5:129.
4. Kino T, Hatanaka H, Hashimoto M, et al. FK506, novel immunosuppressant isolated from a Streptomyces. 1. Fermentation, isolation, and physico-chemical and biological characteristics. J Antibiot. 1987;40:1249-1255.
5. Kino T, Hatanaka H, Miyata S, et al. FK-506. a novel immunosuppressant isolated from a Streptomyces. II. Immunosuppressive effect of FK-506 in vivo. J Antibiot. 1987;40:1256-1265.
6. Kino T, Imamura M, Sakai S, et al. Effect of FK-506 on human mixed lymphocyte reaction in vitro. Transplant Proc. 1987; 19:36-39.
7. Tocci MJ, Makovich DA, Collier KA, et al. The immunosuppressant FK-506 selectively inhibits expression of early T cell activation genes. J Immunol. 1989; 143:718-726.
8. Sawada S, Suzuki G, Kawase Y, Takaku F. Novel immunosuppressive agent, FK-506: In vitro effects on the cloned T cell activation. J Immunol. 1987; 139:1797-1803.
9. Thomas J, Matthews C, Carroll R, Loreth R, Thomas F. The immuno-suppressive action of FK-506: In vitro induction of allogeneic unresponsiveness in human CTL precursors. Transplantation. 1990;49:390-396.
10. Yoshimura N, Matsui S, Harnashima T, Oka T. Effects of a new immunosuppressive agent, FK506, on human lymphocyte response in vitro. 1. Inhibition of expression of alloreactivity. Transplantation. 1989;47:351-356.
11. Hunter PA, Garner A, Wilhelmus KR, Rice NSC, Jones BR. Corneal graft rejection: A new rabbit model and cyclosporin A. Br J Ophthalmol. 1982;66:292-302.
12. Shepherd WFI, Coster DJ, Chin Fook T, Rice NSC, Jones BR. Effect of cyclosporin A on the survival of corneal grafts in rabbits. Br J Ophthalmol. 1980;64:148-153.
13. Williams KA, Erickson SA, Coster DJ. Topical steroid, cyclosporin A, and the outcome of rat corneal allografts. Br J Ophthalmol. 1987;71:239-242.
14. Fujino Y, Chan CG, de Smet MD, et al. FK506 treatment of experimental autoimmune uveoretinitis in primates. Transplant Proc. 1991;23:3335-3338.
15. Nishi M, Herbort CP, Matubara M, et al. Effect of the immunosuppressant FK506 on a penetrating keratoplasty rejection model in the rat. Invest Ophthalmol Vis Sci. 1993;34:2477-2486.
16. Mochizuki M, Masuda M, Sakane T, et al. Clinical trial of FK506 in refractory uveitis. Am J Ophthalmol. 1993; 115:763-769.
17. Hikita N, Chan CG, Whitcup SM, et al. Effects of topical FK506 on endotoxin-induced uveitic (EIU) in the Lewis rats. Curr Eye Res. 1995; 14:209-214.
18. Herbert CP, Matsubara M, Nishi M, Mochizuki M. Penetrating keratoplasty in the rat: Model for the study of immunosuppressive treatments on graft rejection. Jpn J Ophthalmol. 1989;33:212-219.
19. Herbort CP, de Smet MD, Roberge FG, et al. Treatment of corneal allograft rejection with the cytotoxin IL-2-PE40. Transplantation. 1991;52:470-474.
20. Gill III TJ, Kunz HW, Misra DN, Cortese Hassett AL. The major histocompatibility complex of the rat. Transplantation. 1987;43:773-785.
21. Hus SM, Rain L, Fanger H. The use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: A comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem. 1981;29:577-580.
22. Ming N, Chan CG, Nussenblatt RB, Mochizuki M. FR900506 (FK506) and 15-Deoxyspergualin (14-DSG) modulate the kinetics of infiltrating cells in eyes with experimental autoimmune uveoretinitis. Autoimmunity. 1990;8:43-51.
23. Starzl TE, Fung J, Venkataramman R, Todo S, Demetrius AJ, Jain A. FK506 for liver, kidney, and pancreas transplantation. Lancet. 1989;28:1000-1004.
24. Kobayashi C, Kanai A, Nakajima A, Okumura K. Suppression of corneal graft rejection in rabbits by a new immunosuppressive agent, FK506. Transplant Proc. 1989;21:3156-3158.
25. Foets B, Missotten L, Vanderveeren P, Gossens W. Prolonged survival of allogenic corneal grafts in rabbits treated with topically applied cyclosporin A: Systemic absorption and local immunosuppressive effect. Br J Ophthalmol. 1985;69:600-603.
26. Todo S, Demetris A, Ueda Y, et al. Renal transplantation in baboons under FK506. Surgery. 1989; 106:444-450.
27. Fujino Y, Mochizuki M, Chan CG, et al. FK506 treatment of S-antigen induce uveitis in primates. Curr Eye Res. 1991; 10:679-690.
28. Kawashima H, Fujino Y, Mochizuki M. Effect of a new immunosuppressive agent, FK506, on experimental autoimmune uveoretinitis in rats. Invest Ophthalmol Vis Sci. 1988;29:1265-1271.
29. Chan CG, Mochizuki M, Nussenblatt RB, et al. T-lymphocyte subsets I experimental autoimmune uveitis. Clin Exp Immunol. 1985;35:103-110.
30. Chan CC, Mochizuki M, Palestein A, et al. Kinetics of T-lymphocyte subsets in the eyes of Lewis rats with experimental autoimmune uveitis. Cell Immunol. 1985;96:430-434.
31. Unanue ER, Allen PM. The basis for the immunoregulatory role of macrophages and other accessory cells. Science. 1987;236:551-557.
32. Chain BM, Kaye PM, Shaw MA. The biochemistry and cell biology of antigen processing. Immunol Rev. 1988; 106:33-58.
33. Mayer DJ, Daar AS, Casey TA, Fabre JW. Localization of HLA-A, B, C and HLA-DR antigens in the human cornea: Practical significance for grafting technique and HLA typing. Transplant Proc. 1983; 15:126-129.
34. Treseler PA, Foulks GN, Sanfilippo F. The expression of HLA antigens by cells in the human cornea. Am J Ophthalmol. 1984;98:763-772.
35. Young E, Stark WJ, Prendergast RA. Immunology of corneal allograft rejection: HLA-DR antigens on human corneal cells. Invest Ophthalmol Vis Sci. 1985;26:571-574.
36. Pepose J, Gardner KM, Nestor MS, Foos RY, Pettit TH. Detection of HLA class I and II antigen in rejected human corneal allografts. Ophthalmology. 1985; 92:1480-1484.
37. Tresler PA, Sanfilippo F. The expression of major histocompatibility complex and leucocyte antigens by cells in the rat cornea. Transplantation. 1986;41:248-251.
38. Whitsett CF, Stulting RD. The distribution of HLA antigens on human corneal tissue. Invest Ophthalmol Vis Sci. 1984;25:519-524.
39. Holland EJ, Chan CC, Weitzig RP, Palestine AG, Nussenblatt RB. Clinical and immunohistologic studies of corneal rejection in the rat penetrating keratoplasty model. Cornea. 1991; 10:374-380.
40. Pober JS, Collins T, Gimbrone MA Jr, et al. Lymphocytes recognize human vascular endothelial and dermal fibroblast la antigens induced by human recombinant immune interferon. Nature. 1983;305:726-729.
41. Wong GHW, Clark-Lewis I, Harris AW, Schrader JW. Effect of cloned interferon-γ on expression of H-2 and Ia antigens on cell lines of hemopoetic, lymphoid, epithelial, fibroblastic and neuronal origin. Eur J Immunol. 1984; 14:52-56.
42. Basham T, Smith W, Lanier L, Morhenn V, Merigan T. Reguration of expression of class II major histocompatibility antigens on human peripheral blood monocytes and Langerhans cells by interferon. Hum Immunol. 1984; 10:83-93.
43. Dreizen N, Whitsett CF, Stuiting RD. Moduration of HLA antigen expression on corneal epithelial and stromal cells. Invest Ophthalmol Vis Sci. 1988;29:933-939.
44. Springer TA. Adhesion receptors of the immune system. Nature. 1990;46:425-434.